PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer.

Abstract excerpt

It has recently been proposed that a three-gene model (SCMGENE) that measures ESR1, ERBB2, and AURKA identifies the major breast cancer intrinsic subtypes and provides robust discrimination for clinical use in a manner very similar to a 50-gene subtype predictor (PAM50). However, the clinical relevance of both predictors was not fully explored, which is needed given that a ~30 % discordance rate between these two...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aurora Kinase A
• Share to Aurora Kinases
• Share to Breast Neoplasms